Delighting Your Customer through Multichannel Customer Engagement

Today's life sciences customers expect service delivered on their terms. They want the convenience of email, phone, web, and face-to-face - all personalized, all coordinated. The typical experience they receive as a consumer.

The New World of the Customer Experience - Not Your Daddy's Call Center

In this webcast, we will talk about how TrialCard's Customer Experience Center has become the focal point of our business - from inbound support for pharmacies, physicians, and patients through teledetailing and whitespace management to insurance verification and marketing research.

Green light, or go slow: What FDA's new draft guidance means for social media in pharma

While not the last word on the subject, the agency's latest social media guidance was a good step forward. This informative webcast is designed to dissect the guidance and help brand directors and communication managers, whether currently engaging in social media or looking to do so, apply the rules now.

Co-pay Programs in the Crosshairs: An Evidence-based Response to Critics

We've heard the continuous drumbeat from payers and PBMs: "Co-pay programs interfere with generic substitution!" "They subvert cost-sharing 'strategies' that payers put in place!" "They increase health care costs!" That's what they say, but what's the real truth? This presentation uses payers' own data to uncover the surprising evidence supporting co-pay offset programs.

Co-pay Programs in the Crosshairs: An Evidence-based Response to Critics

We've heard the continuous drumbeat from payers and PBMs: "Co-pay programs interfere with generic substitution!" "They subvert cost-sharing 'strategies' that payers put in place!" "They increase health care costs!" That's what they say, but what's the real truth? This presentation uses payers' own data to uncover the surprising evidence supporting co-pay offset programs.

Using Analytics to Maximize Copay Program Effectiveness

As manufacturers began to shift from pure product sampling strategies to more blended ones comprised of sampling, vouchers, and copays, the advantages generated were clearly evident: the entire cost of the product was no longer always being subsidized. As such, manufacturers were content to receive data on the numbers of redemptions, patients, and prescribers participating. However, as the copay industry has matured, these measures have become less and less adequate. Instead, pharmaceutical manufacturers are looking to analytics, with their rich sources of evidence, demonstrations of convincing payback, and sophisticated predictive models as requirements of their patient access suppliers. In this webcast, TrialCard provides an overview of the analytic data that we use to help our manufacturers to design the most effective campaigns and to assess their effectiveness.

Effective targeting to healthcare professional audiences

Two presenters will be exploring effective targeting to healthcare professional audiences from two different perspectives. Scott Weintraub will discuss the value in segmenting the physician audience by geography, and R.J. Lewis will explain how informed targeting to authenticated prescribers can be done effectively online.

How marketing tactics affect patient adherence

Healthcare providers agree that the toughest challenge to treating patients is neither the effectiveness of their medication, nor issues with access and affordability. It's getting the patient to take their medicine as prescribed. And for the brand marketer, the new growth frontier resides on the sloping shoulders of patient adherence.

Making Big Data and Advanced Analytics Work in Pharma Marketing

Pharmaceutical marketers are grappling with both the exciting potential and daunting challenges associated with Big Data. By focusing on the wealth of data captured from non-personal promotions and inbound and outbound prescriber interactions, marketers can apply advanced analytics to create a 360 view of their customer and deliver relevant, personalized offers.

Why is Regional Marketing So Hot?

Audience will learn how regional marketing can benefit your brand's position; how to make regional marketing simple and executable; and the value of a district level driver analysis and how this can become the foundation of regional marketing intelligence

Analyzing Online Conversations: What Social Media Can Teach Us about the Patient Journey

Healthcare consumers are flocking to the social Web to post about their experiences with a given disease and the treatments they hope will help fight it. State-of-the-art search software is available to capture and process these conversations, meaning pharma has access to a wealth of consumer dialogues. Yet 'listening' to patients doesn't mean we're hearing them. Jeff Greene and Susan Eno Collins will present findings from a mining effort of thousands of online conversations about rheumatoid arthritis, along with the implications for brands across every disease category.

Analyzing Online Conversations: What Social Media Can Teach Us about the Patient Journey

Healthcare consumers are flocking to the social Web to post about their experiences with a given disease and the treatments they hope will help fight it. State-of-the-art search software is available to capture and process these conversations, meaning pharma has access to a wealth of consumer dialogues. Yet 'listening' to patients doesn't mean we're hearing them. Jeff Greene and Susan Eno Collins will present findings from a mining effort of thousands of online conversations about rheumatoid arthritis, along with the implications for brands across every disease category.

A brand new way to capture behavior metrics and unlock ROI across integrated channels

As the healthcare landscape becomes increasingly digital, and pharma marketers integrate e-tactics with offline activities, there is a need to better understand how integrated strategies impact ROI. In this special webcast event, we will explore how a new technology platform called CurametRx is closing the loop on Rx analysis by capturing behavior metrics at the sales representative, medical office, patient, and pharmacy level to provide a 360° view of patient engagement journeys.

Life After the FDA Social Media Hearings: Applying the rules today

With the FDA Internet and social media hearings now complete, many Pharma marketers are left trying to answer the question, "what am I supposed to do TODAY?" Formal guidance may not be issued until 2011, yet marketers still have the need to execute digital programs responsibly.

An inside perspective on the FDA online DTC hearings

Join Everyday Health and the IAB for a first-hand look at the issues surrounding the FDA's request for guidance on digital guidelines. From the five questions posed by the FDA to the industry's response at the hearings on November 12-13, Ben Wolin, CEO and Co-Founder of the largest online health property, and Mike Zaneis, VP of Public Affairs of the IAB, will provide a full wrap up, analysis and next steps for the industry. The FDA's last public meeting on online advertising was in1996, so this is an important issue with great implications.

Mobile Marketing to Doctors: How to Make a Meaningful Connection

As the world moves into a digital environment--so are physicians. HCPs are typically among the first to adopt new technology as it applies to their profession, including the use of mobile.

From Selling Pills to Selling Health Care

As the pharmaceutical industry embarks on a dramatic shift from "selling pills" to "selling better health outcomes," drug manufacturers are increasingly focused on improving adherence to therapy and supporting patient wellness.

How to make your digital ads work

Experts from pharma marketing and interactive advertising will look at what makes digital display ads work, exploring some the key elements to achieving campaign objectives and maximizing results, including awareness, brand engagement, specific direct response activity and click through.

Personal and Private: Can You Really Have It All?

Marketers today know the value of one-to-one marketing, but it's difficult to reach your audience on a personal level while still protecting the consumer's right to privacy. The problem is especially acute for pharmaceutical and wellness brands because few topics are as personal and closely guarded as an individual's health.

Maximizing Marketing Outcomes from the Physician-Patient Interchange

The critically important interchange between physician and patient yields the decisions that determine pharmaceutical marketing success or failure. Adding to the complexity of this care-focused dynamic are significant influences on patient diagnosis and ultimately the choice of treatment. The physician is influenced to a great extent by external forces including health plan policies, professional guidelines, clinical information, and internally by experience, education, culture, and personal values. Patients are influenced by many of the same with regard to experience, education, culture, and personal values, as well as interest in self management and the impact the disease is having on their lives. This program will explore the means to maximize marketing outcomes, despite the significant forces that impact the critical decisions made, during the physician-patient interchange.

New Adventures in ROI Measurement

In this special webcast event, experts in the field of pharmaceutical marketing, media and measurement will discuss definitions of campaign effectiveness, how to measure it, how to interpret the data and improve your measurement of ROI, investigate the challenges of measuring campaign effectiveness across different channels, and using case-based studies to explore the merits of self-reported surveys and script-level purchase behavior.

Understanding and Priming the Pre-Visit Patient

The point at which a patient plans and schedules a visit to their doctor represents a significant window of opportunity for promoting treatment options and maximizing the growth of specific brands. Experts in patient engagement and marketing from the pharmaceutical, agency and media fields discuss pharma's role in priming the pre-visit patient for a more beneficial dialogue with their physician.

Increasing Marketing Efficiency While Maximizing Brand Growth

Understanding which marketing tactics to deploy through which channels to best reach particular customer segments is a critical challenge to pharma marketers today. Discovering the most effective combination of tactics and channels will allow you to focus your marketing on the tactics that are working for a particular audience segment and readjust future marketing spend to maximize ROI. In Increasing Marketing Efficiency While Maximizing Brand Growth learn how industry experts leverage database marketing in conjunction with promotional optimization modeling to identify a predictive roadmap for their marketing.

Opening the Door to the Medical Group Practice, Part 1

In the first of two podcasts, William Jessee, MD, FACMPE, president and CEO of the Medical Group Management Association, talks to MM&M editor in chief James Chase about medical group practice managers and administrators - a decision-making audience that, collectively, purchases over $135 billion a year in products and services.

Maximizing your message with integrated cross-platform program

As the media landscape continues its transformation, pharmaceutical marketers and their partners must develop programs that transcend traditional boundaries and capture the benefits of media integration. But what's the best way to leverage the synergies of print, online and beyond with a consistent message that will drive patients' actions and, ultimately, brand business? Pharmaceutical, agency and media experts offer their insights.Sponsored by Health.com

How to get the right DTC mix - and measure the ROI

Experts from the fields of pharma marketing, measurement and consumer media will discuss the challenges facing DTC marketers, and will investigate how best to allocate budgets across consumer channels and measure ROI. Sponsored by WebMD

Overcoming the 6 challenges of CME with innovative media

MM&M hosts an interactive panel discussion to weigh the relevant issues confronting CME planners and sponsors. Our panel of experts will help participants understand how they can apply best practice learning principles, as well as new media options, to achieve measurable results. To learn how to maximize the value of education grants, engage busy medical professionals, and meet your objectives, register for this program today. Sponsored by ReachMD

Email Newsletters